UCSF unveils model for implantable artificial kidney to replace dialysis
September 1, 2010 by admin · Leave a Comment
UCSF researchers today unveiled a prototype model of the first implantable artificial kidney, in a development that one day could eliminate the need for dialysis.
The device, which would include thousands of microscopic filters as well as a bioreactor to mimic the metabolic and water-balancing roles of a real kidney, is being developed in a collaborative effort by engineers, biologists and physicians nationwide, led by Shuvo Roy, PhD, in the UCSF Department of Bioengineering and Therapeutic Sciences.
Millions of Americans in early stages of kidney disease need stroke monitoring
July 27, 2010 by admin · Leave a Comment
WINSTON-SALEM, N.C. Wednesday, July 28, 2010 Millions of Americans in the early stages of chronic kidney disease (CKD) are at an increased risk of having atrial fibrillation (AF) a major risk factor for stroke according to new research by investigators at Wake Forest University Baptist Medical Center.
Heart beat may provide clues to kidney health
July 9, 2010 by admin · Leave a Comment
Abnormal rates increase risk of kidney disease
Individuals with a high resting heart rate and a low beat-to-beat heart rate variability have an increased risk of developing kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The findings suggest that the behavior of the autonomic nervous system may be a sentinel marker for late development of certain cases of kidney disease.
TGen-led studies identify genetic links to kidney disease, kidney failure
June 25, 2010 by admin · Leave a Comment
Findings released at American Diabetes Association conference in Orlando
PHOENIX, Ariz. June 26, 2010 Researchers at the Translational Genomics Research Institute (TGen) will make two presentations at this week’s 70th Scientific Sessions of the American Diabetes Association, June 25-29, in Orlando, Florida.
Genetically modified cell procedure may prove useful in treating kidney failure
June 21, 2010 by admin · Leave a Comment
INDIANAPOLIS A protein whose primary role is in the embryonic development of kidneys may play a future role in treating kidney failure.
Indiana University School of Medicine researchers have successfully treated acute kidney injury in laboratory experiments using cells that were genetically reprogrammed to produce the protein. The research suggests there could be a potential future treatment using such cells delivered intravenously instead of surgically.
Findings provide new therapeutic route for rare kidney disease
June 13, 2010 by admin · Leave a Comment
Scientists from the University of Leeds have discovered the mechanisms of a protein known to play an active part in the inherited kidney disorder, Dent’s disease. The findings provide a new focus for future therapies for the disease, for which there is currently no cure.
Limiting blood flow interruption during kidney surgery avoids chronic kidney disease
June 10, 2010 by admin · Leave a Comment
ROCHESTER, Minn. — Interrupting the blood flow for more than 20 to 25 minutes during kidney cancer (http://www.mayoclinic.org/kidney-cancer/research.html) surgery leads to a greater risk for patients developing chronic kidney disease, a Mayo Clinic and Cleveland Clinic collaborative research team has found. The study was published today in the journal, European Urology.
Gout drug benefits kidney disease patients
Allopurinol helps kidney function and cuts heart risks
A drug commonly used to treat gout may help maintain kidney disease patients’ health, according to an analysis appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). The research is the first to show that allopurinol treatment in patients with chronic kidney disease (CKD) decreases inflammation, slows the progression of kidney disease, and reduces patients’ risk of experiencing a cardiovascular event or being hospitalized.
Popular cancer drug can cause kidney damage
June 9, 2010 by admin · Leave a Comment
Bevacizumab increases the risk of severe urinary protein loss by more than four-fold
The widely used cancer drug bevacizumab may cause severe loss of protein from the kidney into the urine that can lead to significant kidney damage and can compromise the efficacy of cancer treatment, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results suggest that physicians should monitor patients’ kidney health when prescribing this angiogenesis inhibitor.
Post-transplant drug may also help patients with common genetic kidney disease
May 12, 2010 by admin · Leave a Comment
Contact: Shari Leventhal
sleventhal@asn-online.org
202-416-0658
American Society of Nephrology Read more
